FDAHealthNovember 14, 2025
Cipla USA, Inc. — Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-412-02
⚠️ CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Is this relevant to me?
- Geography
- Nationwide
- Source agency
- FDA
- Category
- Health
- Published
- November 14, 2025
Nationwide in the US
What's affected?
- Product
- Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-412-02
- Brand
- CINACALCET
- Lot code
- 5PB0183
Additional details
Lot 5PB0183, exp 1/31/2027
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 12,576 bottles.
Get Health recall alerts
Delivered to your inbox. Free. No account required.